Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000885590-14-000080)

Filing Details

Accession Number:: 0000885590-14-000080
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-03 16:48:14
Reporting Period:: 2014-12-03

Filing Date:: 2014-12-03
Accepted Time:: 2014-12-03 16:48:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1232227	Berghuis Katharine Stevenson	2150 St. Elzear Blvd. Laval A8 H7L 4A8		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2014-12-03	1,500	$145.73	23,098	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This number represents the weighted average purchase price for all purchases of common stock. Actual purchases were in the range of $145.68 and $145.83. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.